Back to results
US 2021/0260100 A1Published application
Glucocerebroside treatment of disease
AssigneeEnzo Therapeutics, Inc.
InventorsYaron Ilan, Maya Margalit, Ari Zimran
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for the treatment of immune mediated or immune related diseases or disorders, infectious diseases, metabolic disorders and cancer in mammalian subjects. This method comprises the administration of a naturally occurring, mammalian intermediary metabolite or T cell receptor ligand, preferably a glucosylceramide, to a mammalian subject. In a preferred embodiment, such mammalian subjects are human beings.
Claims10
A method for improving glucose tolerance in a mammal, comprising:
- administering to a mammalian subject in need of increased glucose tolerance a pharmaceutical composition comprising an amount of glucocerebroside effective to increase glucose tolerance in the mammal, wherein as a result of said administration glucose tolerance in the mammal is increased.
Dependencies are inferred from the claim text.